Development of a helper-independent human adenovirus vector and its use in the transfer of the herpes simplex virus thymidine kinase gene

No abstract is available for this paper.

• Publication year

  1986

• Venue

  Journal of Virology

• Publication date

  1986-01-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1128/jvi.57.1.267-274.1986PMID 3001349PMCID PMC252723
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mapping the 5' ends, 3' ends, and splice sites of mRNAs from the early E3 transcription unit of adenovirus 5.

  1985cited by this paper
• Construction of nondefective adenovirus type 5 bearing a 2.8-kilobase hepatitis B virus DNA near the right end of its genome

  1985influential reference
• Organization and Control of the mRNA of the HSV TK Gene

  1985cited by this paper
• Overproduction of the protein product of a nonselected foreign gene carried by an adenovirus vector.

  1985cited by this paper
• An adenovirus vector system used to express polyoma virus tumor antigens.

  1985cited by this paper
• DNA sequence of the early E3 transcription unit of adenovirus 5.

  1985cited by this paper
• Infection of eucaryotic cells by helper-independent recombinant adenoviruses: early region 1 is not obligatory for integration of viral DNA

  1984cited by this paper
• Efficient transformation of human fibroblasts by adenovirus-simian virus 40 recombinants

  1984cited by this paper
• The Structure of the Genome

  1984cited by this paper
• Expression from an internal AUG codon of herpes simplex thymidine kinase gene inserted in a retrovirus vector

  1984cited by this paper
• Expression of complete chicken thymidine kinase gene inserted in a retrovirus vector

  1984cited by this paper
• High-frequency deletion in recovered retrovirus vectors containing exogenous DNA with promoters

  1984cited by this paper
• Prospects for human gene therapy.

  1984cited by this paper
• The adenovirus type 5 E1A transcriptional control region contains a duplicated enhancer element.

  1983cited by this paper
• Generation of adenovirus by transfection of plasmids.

  1983influential reference
• Translational control of SV40 T antigen expressed from the adenovirus late promoter.

  1983cited by this paper
• Construction of adenovirus expression vectors by site-directed in vivo recombination.

  1982cited by this paper
• Tn5 mutagenesis of the transforming genes of human adenovirus type 5.

  1982cited by this paper
• Avian leukosis virus-induced tumors have common proviral integration sites and synthesize discrete new RNAs: oncogenesis by promoter insertion.

  1981cited by this paper
• Activation of a cellular onc gene by promoter insertion in ALV-induced lymphoid leukosis

  1981cited by this paper
• Construction of an adenovirus-SV40 recombinant producing SV40 T antigen from an adenovirus late promoter.

  1981cited by this paper
• Adenovirus type 5 virions can be assembled in vivo in the absence of detectable polypeptide IX

  1981cited by this paper
• Analysis of avian leukosis virus DNA and RNA in bursal tumours: viral gene expression is not required for maintenance of the tumor state.

  1981cited by this paper
• On the mechanism of retrovirus-induced avian lymphoid leukosis: deletion and integration of the proviruses.

  1981cited by this paper
• Mechanism of activation of early viral transcription by the adenovirus E1A gene product.

  1981cited by this paper
• Expression of SV40 T antigen under control of adenovirus promoters.

  1981cited by this paper
• Multiple mRNA species for the precursor to an adenovirus-encoded glycoprotein: identification and structure of the signal sequence.

  1980cited by this paper
• Nucleotide sequence of the EcoRI D fragment of adenovirus 2 genome.

  1980cited by this paper
• Construction in vitro and rescue of a thymidine kinase-deficient deletion mutation of herpes simplex virus

  1980cited by this paper
• Nucleotide sequence of the EcoRI E fragment of adenovirus 2 genome.

  1980cited by this paper
• Isolation of adenovirus type 5 host range deletion mutants defective for transformation of rat embryo cells.

  1979cited by this paper
• Pre-early adenovirus 5 gene product regulates synthesis of early viral messenger RNAs.

  1979cited by this paper
• Adenovirus 5 DNA sequences present and RNA sequences transcribed in transformed human embryo kidney cells (HEK-Ad-5 or 293).

  1979cited by this paper
• Control of herpes simplex virus type 1 mRNA synthesis in cells infected with wild-type virus or the temperature-sensitive mutant tsK

  1979cited by this paper
• An adenovirus type 5 early gene function regulates expression of other early viral genes.

  1979cited by this paper
• Mapping temperature-sensitive and host-range mutations of adenovirus type 5 by marker rescue.

  1978cited by this paper
• Defective transforming capacity of adenovirus type 5 host-range mutants.

  1978cited by this paper
• Characteristics of a human cell line transformed by DNA from human adenovirus type 5.

  1977cited by this paper
• Biological activity of tumor virus DNA.

  1977cited by this paper
• Adenovirus transcription.

  1976cited by this paper
• Simian virus 40-specific polypeptides in AD2+ ND1- and Ad2+ ND4-infected cells

  1976cited by this paper
• Possible peptide chain termination mutants in thymide kinase gene of a mammalian virus, herpes simplex virus.

  1975cited by this paper
• Use of Nondefective Adenovirus-Simian Virus 40 Hybrids for Mapping the Simian Virus 40 Genome

  1973cited by this paper
• A new technique for the assay of infectivity of human adenovirus 5 DNA.

  1973cited by this paper
• Two types of ribosome in mouse-hamster hybrid cells.

  1971cited by this paper
• Selective extraction of polyoma DNA from infected mouse cell cultures.

  1967cited by this paper
• DELETION OF THYMIDINE KINASE ACTIVITY FROM L CELLS RESISTANT TO BROMODEOXYURIDINE.

  1963cited by this paper
• Genetics of human cess line. IV. DNA-mediated heritable transformation of a biochemical trait.

  1962cited by this paper

• Seroprevalence of Neutralizing Antibodies in Healthy Adults, in Mexico, Against Human and Simian Adenovirus Types

  2025cites this paper
• Comparative analysis of the impact of 40 adenovirus types on dendritic cell activation and CD8+ T cell proliferation capacity for the identification of favorable immunization vector candidates

  2023cites this paper
• Seroprevalence of Binding and Neutralizing Antibodies against 39 Human Adenovirus Types in Patients with Neuromuscular Disorders

  2022cites this paper
• Effect of Transgene Location, Transcriptional Control Elements and Transgene Features in Armed Oncolytic Adenoviruses

  2020cites this paper
• Adenovirus Vector

  2020cites this paper
• Lessons learned from adenovirus (1970–2019)

  2019cites this paper
• DECREASING GENE EXPRESSION IN A MAMMALIAN SUBJECT IN VIVO VIA AAV-MEDIATED RNA EXPRESSION CASSETTE TRANSFER BACKGROUND OF INVENTION

  2017cites this paper
• Future Prospects for the Development of Cost-Effective Adenovirus Vaccines.

  2017cites this paper
• Future Prospects for the Development of Cost-Effective Adenovirus Vaccines

  2017cites this paper
• METHODS AND COMPOSITIONS RELATED TOIMPROVING PROPERTIES OF PHARMACOLOGICAL AGENTS TARGETING NERVOUS SYSTEM

  2017cites this paper
• Blocking Immunosuppressive Factors and Taking Advantage of the Nutrient Supply Within the Tumor Microenvironment: Pathways to Achieve Improved Cancer Immunotherapeutic Efficacy for Patients With Metastatic Melanoma

  2016cites this paper
• Therapeutic applications of endothelial progenitor cells for diabetic ulcer healing

  2016influential citation
• Recent Progress in Strategies for Adenovirus Mediated Therapeutic Cell Targeting

  2016cites this paper
• NAHEMS Guidelines: Vaccination for Contagious Diseases, Appendix A: Foot-and-Mouth Disease

  2015cites this paper
• EBNA1-specific T cell responses during persistent rhesus LCV infection and the development of a novel therapeutic prototype vaccine for EBV-associated diseases

  2014cites this paper
• FMD Vaccine Surge Capacity for Emergency Use in the United States

  2014cites this paper
• STRATEGIES FOR PREVENTION AND TREATMENT OF HEPATITIS C VIRUS INFECTION

  2012cites this paper
• Adenovirus-vectored drug–vaccine duo as a potential driver for conferring mass protection against infectious diseases

  2011cites this paper
• Viral Expression Vectors

  2011cites this paper
• The potential of a novel Adenovirus vector for vaccination.

  2010influential citation
• In vitro dynamic visualization analysis of fluorescently labeled minor capsid protein IX and core protein V by simultaneous detection.

  2010cites this paper
• Magselectofection: A novel integrated technology of magnetic separation and genetic modification of target cells

  2010cites this paper
• Suppression of adenoviral-induced host immune response by TGFβ1 expression

  2009cites this paper
• Adenovirus receptors: implications for tropism, treatment and targeting

  2009cites this paper
• Effect of Pluronic F-68, 5% CO2 Atmosphere, HEPES, and Antibiotic- Antimycotic on Suspension Adapted 293 Cells

  2008cites this paper
• Immune response to helper dependent adenoviral mediated liver gene therapy: challenges and prospects.

  2007cites this paper
• Adenovirus capsid chimeras: fiber terminal exon insertions/gene replacements in the major late transcription unit.

  2007cites this paper
• 7 – Gene Therapy Approaches in Neurology

  2007cites this paper
• ADENOVIRAL VECTORS FOR PROTEIN EXPRESSION

  2007cites this paper
• Gene Therapy to the Nervous System

  2006cites this paper
• Vectors and Gene Therapy

  2006cites this paper
• Transduction of murine and human tumors using recombinant adenovirus vectors

  2006cites this paper
• advances in genetics * progres en genetique I GENE THERAPY : HERE TO STAY

  2005cites this paper
• Cross‐species transfer of viruses: implications for the use of viral vectors in biomedical research, gene therapy and as live‐virus vaccines

  2005cites this paper
• Current Perspectives The Advent of Adenovirus Gene Therapy for Cardiovascular Disease

  2005cites this paper
• Production and formulation of adenovirus vectors.

  2005cites this paper
• Adenoviruses as vaccine vectors

  2004cites this paper
• A novel attenuated replication-competent adenovirus for melanoma therapy

  2003cites this paper
• Gene therapy with viral vectors.

  2003cites this paper
• Development of Attenuated Replication Competent Adenoviruses (ARCAs) for the Treatment of Prostate Cancer

  2002cites this paper
• Subcutaneous Administration of a Replication-Competent Adenovirus Expressing HSV-tk to Cotton Rats: Dissemination, Persistence, Shedding, and Pathogenicity

  2002cites this paper
• Gene therapy: promises and problems.

  2001cites this paper
• A simple procedure for expression and purification of selected non-structural (alpha and beta) herpes simplex virus 1 (HSV-1) proteins.

  2001cites this paper
• A simple procedure for expression and purification of selected non-structural (α and β) herpes simplex virus 1 (HSV-1) proteins

  2001cites this paper
• Prevalence of antibodies to human adenovirus type 5 in Belgian cattle

  2001cites this paper
• Recombinant adenovirus vectors expressing interleukin‐5 and ‐6 specifically enhance mucosal immunoglobulin A responses in the lung

  2000cites this paper
• Development of replication-defective adenovirus serotype 5 containing the capsid and 3C protease coding regions of foot-and-mouth disease virus as a vaccine candidate.

  1999cites this paper
• Generation of infectious genome of bovine adenovirus type 3 by homologous recombination in bacteria.

  1999cites this paper
• The addition of adenovirus type 5 region E3 enables calydon virus 787 to eliminate distant prostate tumor xenografts.

  1999cites this paper
• Adenoviral transduction efficiency partly correlates with expression levels of integrin alphavbeta5, but not alphavbeta3 in human gastric carcinoma cells.

  1998cites this paper
• Permissivity of human HeLa cells to bovine adenovirus type 2 (BaV2 infection

  1998cites this paper
• Cardiovascular Gene Therapy: Principles and Clinical Applications

  1998cites this paper
• Long-lasting adenovirus transgene expression in mice through neonatal intrathymic tolerance induction without the use of immunosuppression

  1997cites this paper
• Generation, validation, and large scale production of adenoviral recombinants with large size inserts such as a 6.3 kb human dystrophin cDNA.

  1997cites this paper
• Human adenovirus vectors for gene transfer into mammalian cells.

  1997cites this paper
• Adenovirus vectors for gene therapy

  1997cites this paper
• Adenovirus as Vectors for Gene Therapy

  1996cites this paper
• MHC Class I-Mediated Antigen Presentation and Induction of CD8+ Cytotoxic T-Cell Responses in Autoimmune Diabetes-Prone NOD Mice

  1996cites this paper
• Pathology and immunogenicity in the cotton rat (Sigmodon hispidus) model after infection with a bovine adenovirus type 3 recombinant virus expressing the firefly luciferase gene.

  1996cites this paper
• Cardiovascular gene therapy: current concepts.

  1996cites this paper
• Introduction of human adenomatous polyposis coli gene into Min mice via cationic liposomes.

  1996cites this paper
• Induction of systemic and mucosal immune responses in cotton rats immunized with human adenovirus type 5 recombinants expressing the full and truncated forms of bovine herpesvirus type 1 glycoprotein gD.

  1996cites this paper
• Long-lived cytotoxic T lymphocyte memory in mucosal tissues after mucosal but not systemic immunization

  1996cites this paper
• [3] Construction and isolation of recombinant adenoviruses with gene replacements

  1995cites this paper
• The cloning and reconstitution of a bovine adenovirus type 2 E3 deletion mutant and the sequencing and analysis of the early 4 region

  1995cites this paper
• Foreign gene expression by human adenovirus type 5-based vectors studied using firefly luciferase and bacterial beta-galactosidase genes as reporters.

  1995cites this paper
• Constitutive episomal expression of polypeptide IX (pIX) in a 293-based cell line complements the deficiency of pIX mutant adenovirus type 5

  1995cites this paper
• Development of a bovine adenovirus type 3-based expression vector.

  1995cites this paper
• Herpes simplex virus glycoprotein K is known to influence fusion of infected cells, yet is not on the cell surface

  1995cites this paper
• Development of Cell Lines Capable of Complementing E1, E4, and Protein IX Defective Adenovirus Type 5 Mutants

  1995cites this paper
• DNA sequence of the deletion/insertion in early region 3 of Ad5 dl309.

  1995cites this paper
• Methods for construction of adenovirus vectors

  1995cites this paper
• Novel biologic therapies for malignant gliomas. Antiangiogenesis, immunotherapy, and gene therapy.

  1995cites this paper
• Adenovirus-mediated gene transfer into striated muscles

  1995cites this paper
• Gene therapy: here to stay.

  1995cites this paper
• Model systems for studying the effects of adenovirus E3 genes on virulence in vivo.

  1995cites this paper
• Evaluation of the Respiratory Epithelium of Normals and Individuals with Cystic Fibrosis for the Presence of Adenovirus E1a Sequences Relevant to the Use of E1a– Adenovirus Vectors for Gene Therapy for the Respiratory Manifestations of Cystic Fibrosis

  1994cites this paper
• Immunogenicity of high expression adenovirus-hepatitis B virus recombinant vaccines in dogs.

  1994cites this paper
• Efficient catheter-mediated gene transfer into the heart using replication-defective adenovirus.

  1994cites this paper
• An efficient and flexible system for construction of adenovirus vectors with insertions or deletions in early regions 1 and 3.

  1994cites this paper
• In Vivo Gene Transfer into the Heart

  1994cites this paper
• Transfert selectif adenoviral de genes vers les cellules neointimales vasculaires

  1994cites this paper
• Somatic gene therapy for cardiovascular disease Recent advances.

  1994influential citation
• Herpes simplex virus (HSV) glycoproteins B and K inhibit cell fusion induced by HSV syncytial mutants.

  1993cites this paper
• Correction of a deletion mutant by gene targeting with an adenovirus vector

  1993cites this paper
• Mucosal immunity and protection after intranasal immunization with recombinant adenovirus expressing herpes simplex virus glycoprotein B.

  1993cites this paper
• Immunogenicity in mice of tandem repeats of an epitope from herpes simplex gD protein when expressed by recombinant adenovirus vectors.

  1993cites this paper
• Diversity of airway epithelial cell targets for in vivo recombinant adenovirus-mediated gene transfer.

  1993cites this paper
• The Advent of Adenovirus Gene Therapy for Cardiovascular Disease

  1993cites this paper
• Activation of RNA polymerase III transcription of human Alu repetitive elements by adenovirus type 5: requirement for the E1b 58-kilodalton protein and the products of E4 open reading frames 3 and 6

  1993cites this paper
• Gene Delivery Systems in Surgery

  1993cites this paper
• Conventional and Biotechnologically Engineered Bovine Vaccines

  1993cites this paper
• Efficient and Selective Adenovirus‐Mediated Gene Transfer Into Vascular Neointima

  1993cites this paper
• Development and Analysis of Recombinant Adenoviruses for Gene Therapy of Cystic Fibrosis

  1993cites this paper
• Human adenovirus type 5 recombinants expressing simian immunodeficiency virus macaque strain gag antigens.

  1993cites this paper
• Packaging capacity and stability of human adenovirus type 5 vectors

  1993cites this paper
• Monitoring foreign gene expression by a human adenovirus-based vector using the firefly luciferase gene as a reporter.

  1993cites this paper
• Gene delivery systems in surgery.

  1993cites this paper
• Synthesis and processing of the haemagglutinin-esterase glycoprotein of bovine coronavirus encoded in the E3 region of adenovirus.

  1992cites this paper
• New treatments for cystic fibrosis.

  1992cites this paper